ADVANZ PHARMA
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · United Kingdom · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
Capital House 85 King William St, London...Phone Number
+44 2085889100Website
www.advanzpharma.comRevenue
$524.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
1
1
1
1
About ADVANZ PHARMA
ADVANZ PHARMA was founded in 2010. This company provides the manufacturing of pharmaceuticals. Their headquarters are located in London, United Kingdom.Explore more
ADVANZ PHARMA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ADVANZ PHARMA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if ADVANZ PHARMA has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ADVANZ PHARMA has new funding data
ADVANZ PHARMA, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if ADVANZ PHARMA had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when ADVANZ PHARMA launches new products
Check out if ADVANZ PHARMA is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ADVANZ PHARMA
Earning: See what the market has to say on ADVANZ PHARMA recently announced quarterly report
Recommended Actions
Find VP level buyers at ADVANZ PHARMA
Find 3 more new buyers
Compare Similar Companies to ADVANZ PHARMA
Compare insights from companies similar to ADVANZ PHARMA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ADVANZ PHARMA
$524.1M
501-1,000
Private
-
2010
JM
John McCleeryManaging Director & Chief Financial Officer
Company Profile Activity
Activity Insights
ADVANZ PHARMA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ADVANZ PHARMA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ADVANZ PHARMA.
ADVANZ PHARMA Tech Stack
A closer look at the technologies used by ADVANZ PHARMA
Most Recent Scoops
Open Position
Person-Based
Pharmaceuticals, Acquisitions
Hiring Plans
ADVANZ PHARMA has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Open Position
ADVANZ PHARMA News & Media
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
REYKJAVIK, Iceland and LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Commission (EC) has granted marketing authorizations in the European EAlvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
REYKJAVIK, ICELAND and LONDON, UK (November 06, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authEuropean Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
LONDON, UK and REYKJAVIK, ICELAND (OCTOBER 6, 2025) — Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVTEuropean Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
LONDON and REYKJAVIK, Iceland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Applicat
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ADVANZ PHARMA
Sign Up For FreeTo access detailed company insights
ADVANZ PHARMA was founded in 2010. This company provides the manufacturing of pharmaceuticals. Their headquarters are located in London, United Kingdom.... Read More
